Gastrointestinal stromal tumor | Tumor

CURE’s gastrointestinal stromal tumor page features the latest cancer news and updates on gastrointestinal stromal tumors Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in the gastrointestinal stromal tumor.

GIST Expert Urges Patients to Seek Specialized Second Opinions

June 30th 2025, 1:00pm

Video

Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.

What Patients With GIST Should Know About Their Disease

June 25th 2025, 4:00pm

Article

Dr. Breelyn Wilky discusses some of the most recent advancements in GIST treatment, as well as touched on the role of personalized therapy.

Personalized Therapy Helps Tailor Treatment for GIST

June 20th 2025, 3:00pm

Video

Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.

HT-KIT Shows Activity in Rare KIT-Driven Cancers, Preclinical Data Finds

May 28th 2025, 7:00pm

Article

Preclinical data has showing compelling findings for HT-KIT among patients with rare and aggressive KIT-driven cancers, including GIST and some leukemias.

Endoscopic Procedure Removes GIST Without Surgery

May 1st 2025, 7:00pm

Article

A new endoscopic tunneling method, STER, allowed a patient to have a GIST removed without surgery, allowing quicker recovery and fewer complications.

First Patient Dosed in Trial of Ziftomenib for Advanced GIST

May 1st 2025, 3:03pm

Article

A phase 1 trial has initiated and is investigating treatment with ziftomenib plus Gleevec in advanced GIST following progression on Gleevec.

SIRT With 90Y Resin Microspheres Provides Benefit in GIST Liver Metastases

April 29th 2025, 1:00pm

Article

SIRT with 90Y resin microspheres led to durable disease control in patients with gastrointestinal stromal tumor liver metastases resistant to TKI therapy.

Alternating Glivec and Stivarga Doesn't Improve Advanced GIST Outcomes

April 28th 2025, 9:00pm

Article

Alternating between Glivec and Stivarga therapy didn't impact survival outcomes; it led to more toxicity and discontinuations in patients with GIST.

Treatment With HT-KIT Shows Early Preclinical Activity in GIST Models

April 27th 2025, 6:00pm

Article

HT-KIT, a novel targeted therapy for GIST, demonstrated the ability to reduce tumor burden in humanized mouse models and induce tumor cell death.

RECKGIST Score May Predict Recurrence in Neurofibromatosis Type 1 GISTs

March 12th 2025, 1:00pm

Article

RECKGIST score may predict recurrence in neurofibromatosis type 1 GISTs, potentially guiding treatment decisions, according to study findings.